Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume

Clinical and Translational Radiation Oncology - Tập 27 - Trang 139-146 - 2021
Linda Nissi1, Sami Suilamo1,2, Eero Kytö3, Samuli Vaittinen4, Heikki Irjala3, Heikki Minn1
1Department of Oncology, University of Turku and Turku University Hospital, Turku, Finland
2Department of Medical Physics, Turku University Hospital, Turku, Finland
3Department of Otorhinolaryngology, Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland
4Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland

Tài liệu tham khảo

Rettig, 2015, Epidemiology of head and neck cancer, Surg Oncol Clin N Am, 24, 379, 10.1016/j.soc.2015.03.001 Moreno, 2019, Intensity modulated proton therapy (IMPT) – the future of IMRT for head and neck cancer, Oral Oncol, 88, 66, 10.1016/j.oraloncology.2018.11.015 Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, 363, 24, 10.1056/NEJMoa0912217 Wookey, 2019, HPV status and survival in non-oropharyngeal squamous cell carcinoma of the head and neck, Anticancer Res, 39, 1907, 10.21873/anticanres.13299 Gillison, 2019, Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial, Lancet, 393, 40, 10.1016/S0140-6736(18)32779-X Mehanna, 2019, Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial, Lancet, 393, 51, 10.1016/S0140-6736(18)32752-1 Mirghani, 2015, Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives, Int J Cancer, 136, 1494, 10.1002/ijc.28847 Minn, 2010, Impact of PET/CT on planning of radiotherapy in head and neck cancer, Q J Nucl Med Mol Imaging, 54, 521 Kytö, 2019, Critical review of the follow-up protocol for head and neck cancer patients, J Laryngol Otol, 133, 424, 10.1017/S0022215119000811 Mehanna, 2016, PET-CT surveillance versus neck dissection in advanced head and neck cancer, N Engl J Med, 374, 1444, 10.1056/NEJMoa1514493 Dawson, 2000, Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, Int J Radiat Oncol Biol Phys, 46, 1117, 10.1016/S0360-3016(99)00550-7 Rawat, 2017, Comparison between weekly cisplatin-enhanced radiotherapy and cetuximab-enhanced radiotherapy in locally advanced head and neck cancer: first retrospective study in Asian population, Asia Pac J Clin Oncol, 13, 195, 10.1111/ajco.12581 Brierley, 2017 Geretschläger, 2012, Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma, Radiat Oncol, 7, 175, 10.1186/1748-717X-7-175 Chen, 2017, Inadequate target volume delineation and local–regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer: local–regional recurrence after IMRT for HPV-positive oropharynx cancer, Radiother Oncol, 123, 10.1016/j.radonc.2017.04.015 Johansen, 2017, Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer, Radiat Oncol, 12, 1, 10.1186/s13014-017-0829-5